TRIAMTERENE AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; TRIAMTERENE) — FDA Approval ANDA073281 (SANDOZ)
TRIAMTERENE AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; TRIAMTERENE) — FDA Approval ANDA073281 (SANDOZ) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: TRIAMTERENE AND HYDROCHLOROTHIAZIDE; Active ingredients: HYDROCHLOROTHIAZIDE; TRIAMTERENE; Application number: ANDA073281.
| Brand name | TRIAMTERENE AND HYDROCHLOROTHIAZIDE |
|---|---|
| Active ingredients | HYDROCHLOROTHIAZIDE; TRIAMTERENE |
| Application number | ANDA073281 |
| Sponsor | SANDOZ |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 19920430 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →